Moberg Pharma AB (publ)
F:MB8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Moberg Pharma AB (publ)
F:MB8
|
SE |
|
Aallon Group Oyj
F:I74
|
FI |
|
M
|
Mensch und Maschine Software SE
XMUN:MUM
|
DE |
|
G
|
Genscript Biotech Corp
OTC:GNNSF
|
CN |
Wall St Price Targets
MB8 Price Targets Summary
Moberg Pharma AB (publ)
According to Wall Street analysts, the average 1-year price target for MB8 is 1.039 EUR with a low forecast of 1.029 EUR and a high forecast of 1.07 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MB8's stock price target?
Price Target
1.039
EUR
According to Wall Street analysts, the average 1-year price target for MB8 is 1.039 EUR with a low forecast of 1.029 EUR and a high forecast of 1.07 EUR.
What is the Revenue forecast for Moberg Pharma AB (publ)?
Projected CAGR
92%
The compound annual growth rate for Revenue over the next 3 years is 92%.
What is the Gross Profit forecast for Moberg Pharma AB (publ)?
Projected CAGR
135%
The compound annual growth rate for Gross Profit over the next 2 years is 135%.
